ClinVar Miner

Submissions for variant NM_000314.7(PTEN):c.-909T>C (rs550385924)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen PTEN Variant Curation Expert Panel RCV000758225 SCV000886860 likely benign PTEN hamartoma tumor syndrome 2018-07-25 reviewed by expert panel curation PTEN c.-909T>C (NC_000010.10:g.87863560T>C) meets criteria to be classified as likely benign for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (PMID 30311380). Please see a summary of the rules and criteria codes in the "PTEN ACMG Specifications Summary" document (assertion method column). BP2: Observed in trans with a pathogenic or likely pathogenic PTEN variant. (internal laboratory contributor ClinVar Organization ID 19864) BP5: Variant found in multiple cases with alternate molecular basis for disease. (internal laboratory contributors SCV000185347.1, SCV000149485.5)
GeneDx RCV000589607 SCV000149485 likely benign not provided 2020-09-15 criteria provided, single submitter clinical testing
Ambry Genetics RCV000115576 SCV000185347 likely benign Hereditary cancer-predisposing syndrome 2013-10-30 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000589607 SCV000889810 uncertain significance not provided 2020-07-10 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000258978 SCV001361380 likely benign not specified 2019-09-23 criteria provided, single submitter clinical testing Variant summary: PTEN c.-910T>C (also known as c.-909T>C) is located in the untranslated mRNA region upstream of the initiation codon. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 4/31172 control chromosomes at a frequency of 0.00013, which is approximately 20 times the estimated maximal expected allele frequency of a pathogenic PTEN variant (0.0000063), suggesting this variant is likely a benign polymorphism. To our knowledge, no occurrence of c.-910T>C in individuals affected with Cowden Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Co-occurrence with another pathogenic variant has been reported (BRIP1 c.2078_2079delGT, p.Cys693fsX23; LCA internal database), providing supporting evidence for a benign role. Two other ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. One expert panel (ClinGen PTEN Variant Curation Expert Panel) cites this variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.